SOADOR
LENZ

State of Alaska Department of Revenue’s LENZ Therapeutics LENZ Stock Holding History

State of Alaska Department of Revenue’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Buy
37,159
+13,000
+54% +$105K ﹤0.01% 1649
2026
Q1 		$221K Buy
24,159
+5,000
+26% +$70.2K ﹤0.01% 1630
2025
Q4 		$306K Buy
+19,159
New +$558K ﹤0.01% 1585

Other funds holding LENZ

VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $78.6B AUM 28.08% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State of Alaska Department of Revenue's LENZ Position: Q2 2026 in Review

State of Alaska Department of Revenue increased its LENZ Therapeutics (LENZ) stake by 54% in Q2 2026, buying an estimated $105K and bringing the position to 37,159 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #1649.

State of Alaska Department of Revenue first reported a position in LENZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $306K in Q4 2025. 66 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • State of Alaska Department of Revenue held 37,159 shares of LENZ Therapeutics worth $211K as of Q2 2026.
  • State of Alaska Department of Revenue bought 13,000 LENZ Therapeutics shares in Q2 2026, an estimated $105K.
  • LENZ Therapeutics made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1649 holding.
  • State of Alaska Department of Revenue first reported a position in LENZ Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • State of Alaska Department of Revenue's LENZ Therapeutics position peaked at $306K in Q4 2025.
  • 66 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.